A federal appeals court has ruled that the abortion pill, mifepristone, can be temporarily available with restrictions. The ruling will hold until the full case is heard on appeal. The decision came after a lower court had allowed medication abortions to be prescribed and dispensed by mail during the pandemic, which was challenged by the Trump administration in July.
Mifepristone is used in medication abortions during the first 10 weeks of pregnancy. Restrictions have been placed on its use since it was approved in 2000, including a requirement that it be dispensed only in clinics or hospitals.
The ruling has been praised by reproductive rights advocates who argue that access to safe and legal abortion should not be limited due to COVID-19 restrictions. However, opponents of abortion have expressed concerns about potential health risks associated with dispensing the drug through telemedicine or mail-in prescriptions.
This decision comes amidst ongoing debates over reproductive rights and healthcare access for women across America. It remains to be seen how this ruling will affect future decisions regarding access to safe and legal abortion services.